Global Healthcare IT Market is expected to grow with the CAGR of 15.8% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report at https://www.databridgemarketresearch.com/reports/global-healthcare-it-market

Global healthcare IT market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global Healthcare IT Market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.

For instance,

• In December 2019, General Electric Company released its new software- SpinOculation C-Pro Protocol Software used for the cell therapy. The uses of software are choosing cell concentrations and volumes from cell preparation from initial stages through transduction to final resuspension. It will help the company to expand its product portfolio and increase its customer base.

McKesson Corporation is the dominating player in global healthcare IT market. The other key players existing in the market includes Novigenix SA, Bioaxis, Ada Health GmbH,  Doctolib,  Ieso Digital Health Ltd.,  Lantum,  Rowa (A Subsidiary OF BD),  Siilo, BigHealth, Vida Health,  SWORD Health,  Carestream Health, Siemens Healthineers AG,  athenahealth, Inc., Agfa-Gevaert Group,  eClinicalWorks, GE Healthcare (A subsidiary of GENERAL ELECTRIC),  GREENWAY HEALTH, LLC.,  Infor,  Koninklijke Philips N.V.,  NextGen Healthcare, Inc.,  Oracle, Epic Systems Corporation, Cerner Corporation and Allscripts Healthcare Solutions, Inc.

McKesson Corporation

McKesson Corporation, headquartered in Texas, U.S which was founded in 1833.  The company offers healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care and healthcare information technology. The company is engaged in manufacturing of various products and their business segments are U.S. Pharmaceutical and speciality solutions, European pharmaceuticals solutions, medical surgical solutions and others, out of which market focused segment is U.S. pharmaceutical and speciality solutions

• For instance, In September 2019, McKesson Corporation and TrakCel announced collaboration for cell therapies and supporting gene. The motive of this innovative collaboration was to provide correct drug in minimum duration to the patients.

The company has wide global presence across the globe such as U.S., Canada and Europe. In addition to it, the company also generates its revenue from the various subsidiary companies such as McKesson Medical-Surgical Inc. (U.S.), McKesson Canada (Canada), CoverMyMeds, LLC. (U.S.), RelayHealth (U.S.), Uniprix (Canada), Rexall Pharmacy Group Ltd. (Canada) among others.

Siemens Healthineers AG

Siemens Healthineers AG is headquartered in Erlangen, Germany. The company is engaged in manufacturing of variety of imaging and diagnostics material for every major industry such as industrial, medical and retail. The company offers wide range of product categories such as medical imaging, laboratory diagnostics, point-of-care testing, service, healthcare IT, refurbished system, education and training and online services, under which healthcare IT is market focused category.

• For instance, In April 2018, Siemens Healthineers AG has implemented Industry 4.0 vision on industry-specific solutions with its Digital Enterprise portfolio. This implementation in Digital Enterprise solutions will help the customers and users to understand the benefits of digital enterprise portfolio usage in various industries in order to secure real competitive benefits.

The company has presence in Europe, North America, South America, Middle East & Africa and Asia-Pacific with its various subsidiaries such as Siemens Healthcare SAS (France), Dedicated2Imaging LLC (United States), Acrorad Co., Ltd., (Japan), Siemens Healthcare d.o.o., (Croatia) and Siemens Healthcare Nederland B.V. (Netherlands) among others.

GE Healthcare (A subsidiary of General Electric)

GE Healthcare (A subsidiary of General Electric) has business segments which are healthcare systems and life sciences among which healthcare systems is market focused segment. The product categories includes accessories and supplies, advanced visualization, anesthesia delivery, bone and metabolic health, computed tomography, contrast media, diagnostic ecg, edison, ep recording, goldseal-refurbished systems, healthcare IT, hemodynamic recording, interoperability, interventional image guided systems, life sciences, magnetic resonance imaging, mammography, maternal infant care, molecular imaging, nuclear imaging agents, patient monitoring, radiography, fluoroscopy systems, surgical imaging, ultrasound and ventilators.

• For instance, In December 2019, General Electric Company partners with Affidea for deploying digital technologies and imaging throughout the Affidea network. This will help GE Healthcare to install and develop new equipment across Europe thus helping in increasing its presence in European market.

The company has wide global presence in Europe, North America, South America, Middle East & Africa and Asia-Pacific. In addition to it, the company also generates its revenue from the various subsidiary companies such as Biacore (Sweden), GE Healthcare Dharmacon, Inc. (U.S.), Nihon Medi-Physics Co., Ltd. (Japan), Medi-Physics, Inc. (U.S.), Hyclone Laboratories Inc (U.S.), Biosafe SA (Switzerland), ONI Medical Systems (U.S.) and Wipro GE Healthcare Pvt. Ltd.( India) among others.